SK284535B6 - Farmaceuticky prijateľná kompozícia na stimuláciu rastu neuritov a použitie zlúčeniny obsiahnutej v tejto kompozícii - Google Patents

Farmaceuticky prijateľná kompozícia na stimuláciu rastu neuritov a použitie zlúčeniny obsiahnutej v tejto kompozícii Download PDF

Info

Publication number
SK284535B6
SK284535B6 SK628-99A SK62899A SK284535B6 SK 284535 B6 SK284535 B6 SK 284535B6 SK 62899 A SK62899 A SK 62899A SK 284535 B6 SK284535 B6 SK 284535B6
Authority
SK
Slovakia
Prior art keywords
group
branched
straight
compound
alkyl
Prior art date
Application number
SK628-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK62899A3 (en
Inventor
Robert E. Zelle
Michael Su
Original Assignee
Vertex Pharmaceuticals Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25009484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284535(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vertex Pharmaceuticals Incorporated filed Critical Vertex Pharmaceuticals Incorporated
Publication of SK62899A3 publication Critical patent/SK62899A3/sk
Publication of SK284535B6 publication Critical patent/SK284535B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK628-99A 1996-11-13 1997-11-13 Farmaceuticky prijateľná kompozícia na stimuláciu rastu neuritov a použitie zlúčeniny obsiahnutej v tejto kompozícii SK284535B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/748,447 US5840736A (en) 1996-11-13 1996-11-13 Methods and compositions for stimulating neurite growth
PCT/US1997/020866 WO1998020891A1 (en) 1996-11-13 1997-11-13 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Publications (2)

Publication Number Publication Date
SK62899A3 SK62899A3 (en) 2000-04-10
SK284535B6 true SK284535B6 (sk) 2005-06-02

Family

ID=25009484

Family Applications (1)

Application Number Title Priority Date Filing Date
SK628-99A SK284535B6 (sk) 1996-11-13 1997-11-13 Farmaceuticky prijateľná kompozícia na stimuláciu rastu neuritov a použitie zlúčeniny obsiahnutej v tejto kompozícii

Country Status (32)

Country Link
US (3) US5840736A (enExample)
EP (1) EP0946190B1 (enExample)
JP (1) JP2001504470A (enExample)
KR (1) KR100544451B1 (enExample)
CN (1) CN1168442C (enExample)
AP (1) AP9901518A0 (enExample)
AR (1) AR011278A1 (enExample)
AT (1) ATE250424T1 (enExample)
AU (1) AU724833B2 (enExample)
BG (1) BG64670B1 (enExample)
BR (1) BR9712765A (enExample)
CA (1) CA2270634A1 (enExample)
CO (1) CO4930260A1 (enExample)
CZ (1) CZ296058B6 (enExample)
DE (1) DE69725169T2 (enExample)
DK (1) DK0946190T3 (enExample)
EA (1) EA004247B1 (enExample)
ES (1) ES2206753T3 (enExample)
HU (1) HU226728B1 (enExample)
IL (1) IL129555A (enExample)
IN (1) IN183740B (enExample)
IS (1) IS2057B (enExample)
NO (1) NO328030B1 (enExample)
NZ (1) NZ335394A (enExample)
PL (1) PL190903B1 (enExample)
PT (1) PT946190E (enExample)
SK (1) SK284535B6 (enExample)
TR (1) TR199901034T2 (enExample)
TW (1) TW513302B (enExample)
UA (1) UA63926C2 (enExample)
WO (1) WO1998020891A1 (enExample)
ZA (1) ZA9710256B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
US6514686B2 (en) 1997-04-28 2003-02-04 The University Of British Columbia Method and composition for modulating amyloidosis
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US5968921A (en) * 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
EP1084106A1 (en) 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
ES2226409T3 (es) 1998-07-17 2005-03-16 Agouron Pharmaceuticals, Inc. Compuestos, composiciones y procedimientos para estimular el crecimiento y elongacion neuronales.
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6228872B1 (en) 1998-11-12 2001-05-08 Bristol-Myers Squibb Company Neurotrophic diamide and carbamate agents
AU2173400A (en) * 1998-12-09 2000-06-26 Chiron Corporation Method for administering agents to the central nervous system
JP2002534414A (ja) * 1999-01-08 2002-10-15 バーテックス ファーマシューティカルズ インコーポレイテッド 医薬の製造に有用な中間体の形成方法
WO2001002368A1 (en) * 1999-07-06 2001-01-11 Vertex Pharmaceuticals Incorporated N-heterocyclic derivatives with neuronal activity
US6734211B1 (en) * 1999-07-09 2004-05-11 Oregon Health & Sciences University Compositions and methods for promoting nerve regeneration
CA2379993A1 (en) * 1999-07-30 2001-02-08 Vertex Pharmaceuticals Incorporated Acyclic and cyclic amine derivatives
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
ATE335524T1 (de) * 1999-11-12 2006-09-15 Alcon Inc Verwendung von neurophilin liganden zur behandlung von augenerkrankungen
US7253169B2 (en) 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en) 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
US7060676B2 (en) * 1999-12-20 2006-06-13 Trustees Of Tufts College T. cruzi-derived neurotrophic agents and methods of use therefor
AU1464101A (en) 1999-12-21 2001-07-03 Gpi Nil Holdings, Inc. Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
AU2002259305A1 (en) * 2001-05-25 2002-12-09 Cornell Research Foundation, Inc. High affinity ligand for p75 neurotrophin receptor
MXPA03011095A (es) * 2001-05-29 2005-04-28 Guilford Pharm Inc Metodo para tratar una lesion nerviosa causada por cirugia.
FR2825273B1 (fr) * 2001-05-29 2006-11-24 Oreal Composition pour le traitement des signes cutanes du vieillissement
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20100247483A1 (en) * 2001-11-13 2010-09-30 Tran Loi H Therapeutic agent composition and method of use
US7232798B2 (en) 2001-11-13 2007-06-19 Tran Loi H Neuroprotection and neuroegenisis by administering cyclic prolyl glycine
WO2003041655A2 (en) * 2001-11-13 2003-05-22 Loi Tran Therapeutic agent composition and method of use
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8841326B2 (en) 2004-02-12 2014-09-23 Stc.Unm Therapeutic curcumin derivatives
EP1988920A1 (en) * 2006-02-02 2008-11-12 Rinat Neuroscience Corp. Methods for treating obesity by administering a trkb antagonist
KR20080091838A (ko) * 2006-02-02 2008-10-14 리나트 뉴로사이언스 코퍼레이션 Ｔｒｋｂ 작용제의 투여에 의한 원치않는 체중 감소 또는 섭식 장애의 치료 방법
EP2114436A1 (en) * 2006-12-20 2009-11-11 Rinat Neuroscience Corp. Trkb agonists for treating autoimmune disorders
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
MA53500A (fr) 2018-05-15 2021-08-18 Lloyd Hung Loi Tran Composition d'agent thérapeutique et procédé d'utilisation, pour le traitement d'un trouble cognitif léger, de la dépression et de troubles psychologiques

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) * 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
JP5720848B2 (ja) * 2012-09-28 2015-05-20 Dic株式会社 多面体形状のα−アルミナ微粒子の製造方法

Also Published As

Publication number Publication date
IN183740B (enExample) 2000-04-01
CN1168442C (zh) 2004-09-29
TW513302B (en) 2002-12-11
SK62899A3 (en) 2000-04-10
JP2001504470A (ja) 2001-04-03
NO992138L (no) 1999-07-13
US6172086B1 (en) 2001-01-09
IL129555A0 (en) 2000-02-29
PL190903B1 (pl) 2006-02-28
NZ335394A (en) 2000-06-23
PT946190E (pt) 2004-02-27
US6284778B1 (en) 2001-09-04
CZ296058B6 (cs) 2006-01-11
BG64670B1 (bg) 2005-11-30
AR011278A1 (es) 2000-08-16
HU226728B1 (en) 2009-08-28
UA63926C2 (uk) 2004-02-16
AU724833B2 (en) 2000-09-28
HUP0001219A2 (hu) 2000-11-28
HK1022851A1 (en) 2000-08-25
TR199901034T2 (xx) 1999-07-21
CZ168399A3 (cs) 1999-08-11
AU5258998A (en) 1998-06-03
CA2270634A1 (en) 1998-05-22
EA004247B1 (ru) 2004-02-26
IL129555A (en) 2005-08-31
ZA9710256B (en) 1998-05-28
BG103429A (en) 2000-04-28
KR20000068962A (ko) 2000-11-25
KR100544451B1 (ko) 2006-01-24
AP9901518A0 (en) 1999-06-30
NO992138D0 (no) 1999-05-03
NO328030B1 (no) 2009-11-16
EA199900464A1 (ru) 2000-02-28
ES2206753T3 (es) 2004-05-16
HUP0001219A3 (en) 2001-12-28
IS2057B (is) 2005-10-14
IS5032A (is) 1999-04-21
ATE250424T1 (de) 2003-10-15
BR9712765A (pt) 1999-10-26
EP0946190A1 (en) 1999-10-06
WO1998020891A1 (en) 1998-05-22
DE69725169D1 (de) 2003-10-30
CO4930260A1 (es) 2000-06-27
DK0946190T3 (da) 2003-12-08
US5840736A (en) 1998-11-24
EP0946190B1 (en) 2003-09-24
PL333270A1 (en) 1999-11-22
CN1239433A (zh) 1999-12-22
DE69725169T2 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
SK284535B6 (sk) Farmaceuticky prijateľná kompozícia na stimuláciu rastu neuritov a použitie zlúčeniny obsiahnutej v tejto kompozícii
KR100537866B1 (ko) Ｆｋｂｐ12에 대해 친화성 있는 화합물과 향신경성 인자를 함께 사용하여 신경 돌기의 성장을 자극하는 방법 및 조성물
EP0941112B1 (en) Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
US6716860B2 (en) Azo amino acids derivatives
JP2003503482A (ja) 環化アミノ酸誘導体
JP2003503500A (ja) 神経学的疾患の治療のためのキヌクリジン誘導体
US6552041B2 (en) Cyclized amide derivatives
JP2003506356A (ja) 神経学的疾患の治療のための環状アミン誘導体
US20020111347A1 (en) Amino-alkyl derivatives
HK1022851B (en) Methods and compositions for stimulating neurite outgrowth
MXPA99004419A (en) Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
JP2003503478A (ja) 神経学的疾患の治療のためのβ−アミノ酸誘導体
MXPA99004421A (en) Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
HK1094309A (en) Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20091113